News

Fintel on MSN6h
Cantor Fitzgerald Initiates Coverage of Apellis Pharmaceuticals (APLS) with Overweight Recommendation
Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of Apellis Pharmaceuticals (NasdaqGS:APLS) with a ...
Investing Snacks22m
Lam Research: From Microchips to Mega Moves
Stifel Financial Corp dialed up its commitment to Lam Research in a move so bold it might’ve short-circuited calculators.